Osamu NAKAGAWA

Dr. Osamu NAKAGAWA


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2018 in Angiogenesis
Verified
Journal Article
Closed access
PDF file
MAMutsumi Araki
Mutsumi Araki
THTakashi Hisamitsu
Takashi Hisamitsu
YKYumi Kinugasa-Katayama
Yumi Kinugasa-Katayama
TTToru Tanaka
Toru Tanaka
YHYukihiro Harada
Yukihiro Harada
ONOsamu NAKAGAWA
Osamu NAKAGAWA

1 May 2020 in Developmental Biology
Verified
Journal Article
Closed access
DIDai Ihara
Dai Ihara
YWYusuke Watanabe
Yusuke Watanabe
DSDaiki Seya
Daiki Seya
YAYuji Arai
Yuji Arai
YIYoshie Isomoto
Yoshie Isomoto
ONOsamu NAKAGAWA
Osamu NAKAGAWA

1 February 2016 in Mechanisms of Development
Verified
Journal Article
Closed access
MFMasahide Fujita
Masahide Fujita
MSMasahide Sakabe
Masahide Sakabe
TITomoko Ioka
Tomoko Ioka
YWYusuke Watanabe
Yusuke Watanabe
YKYumi Kinugasa-Katayama
Yumi Kinugasa-Katayama
ONOsamu NAKAGAWA
Osamu NAKAGAWA

7 January 2021 in Development, Growth & Differentiation
Verified
Journal Article
Closed access
PDF file
DSDaiki Seya
Daiki Seya
DIDai Ihara
Dai Ihara
TKTeruhisa Kawamura
Teruhisa Kawamura
YWYusuke Watanabe
Yusuke Watanabe
ONOsamu NAKAGAWA
Osamu NAKAGAWA

1 December 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YWYusuke Watanabe
Yusuke Watanabe
DSDaiki Seya
Daiki Seya
DIDai Ihara
Dai Ihara
SIShuhei Ishii
Shuhei Ishii
TUTaiki Uemoto
Taiki Uemoto
ONOsamu NAKAGAWA
Osamu NAKAGAWA
Thoracic great vessels such as the aorta and subclavian arteries are formed through dynamic remodeling of embryonic pharyngeal arch arteries (PAAs). Previous work has shown that loss of a basic helix-loop-helix transcription factor Hey1 in mice causes abnormal 4th PAA development and lethal great vessel anomalies resembling congenital malformations in humans. However, how Hey1 mediates vascular formation remains unclear. In this study, we revealed that Hey1 in vascular endothelial cells, but not in smooth muscle cells, played essential roles for PAA development and great vessel morphogenesis in mouse embryos. Tek-Cre-mediated Hey1 deletion in endothelial cells affected endothelial tube formation and smooth muscle differentiation in embryonic 4th PAAs and resulted in interruption of the aortic arch and other great vessel malformations. Cell specificity and signal responsiveness of Hey1 expression were controlled through multiple cis-regulatory regions. We found two distal genomic regions that had enhancer activity in endothelial cells and in the pharyngeal epithelium and somites, respectively. The novel endothelial enhancer was conserved across species and was specific to large caliber arteries. Its transcriptional activity was regulated by Notch signaling in vitro and in vivo, but not by ALK1 signaling and other transcription factors implicated in endothelial cell specificity. The distal endothelial enhancer was not essential for basal Hey1 expression in mouse embryos but may likely serve for Notch-dependent transcriptional control in endothelial cells together with the proximal regulatory region. These findings help understand significance and regulation of endothelial Hey1 as a mediator of multiple signaling pathways in embryonic vascular formation.

5 September 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
YWYusuke Watanabe
Yusuke Watanabe
YWYunce Wang
Yunce Wang
YTYuki Tanaka
Yuki Tanaka
AIAkiyasu Iwase
Akiyasu Iwase
TKTeruhisa Kawamura
Teruhisa Kawamura
ONOsamu NAKAGAWA
Osamu NAKAGAWA
The cardiac crescent is the first structure of the heart and contains progenitor cells of the first heart field, which primarily differentiate into left ventricular cardiomyocytes. The interface between the forming cardiac crescent and extraembryonic tissue is known as the juxta-cardiac field (JCF), and progenitor cells in this heart field contribute to the myocardium of the left ventricle and atrioventricular canal as well as the epicardium. However, it is unclear whether there are progenitor cells that differentiate specifically into left ventricular cardiomyocytes. We have previously demonstrated that an enhancer of the gene encoding the Hey2 bHLH transcriptional repressor is activated in the ventricular myocardium during mouse embryonic development. In this study, we aimed to investigate the characteristics of cardiomyocyte progenitor cells and their cell lineages by analyzing Hey2 enhancer activity at the earliest stages of heart formation. We found that the Hey2 enhancer initiated its activity prior to cardiomyocyte differentiation within the JCF. Hey2 enhancer-active cells were present rostrally to the Tbx5 -expressing region at the early phase of cardiac crescent formation and differentiated exclusively into left ventricular cardiomyocytes in a lineage distinct from the Tbx5 -positive lineage. By the late phase of cardiac crescent formation, Hey2 enhancer activity became significantly overlapped with Tbx5 expression in cells that contribute to the left ventricular myocardium. Our study reveals that a population of unipotent progenitor cells for left ventricular cardiomyocytes emerge in the JCF, providing further insight into the mode of cell type diversification during early cardiac development.